Skip to main content

Table 2 Clinical manifestations of MS patients along MS course

From: The relationship of HLA-G 14-bp insertion/deletion genetic polymorphism to the risk of multiple sclerosis and its clinical phenotypes

  Number Percentage
Ocular manifestations
 Optic neuritis   
  Diminution of vision 19 39%
  Field defects 12 25%
  Abnormal color vision 2 4.1%
  Total 33 68.1%
 Ocular motor   
  Nystagmus 11 22.9%
  Internuclear ophthalmoplegia 7 14.5%
  Ocular flutter 3 6.25%
  Abducens palsy 2 4.16%
  Total 23 47.9%
Motor manifestations
 Hemiparesis 20 41.7%
 Monoparesis 4 8.3%
 Paraparesis 5 10.4%
 Quadriparesis 5 10.4%
 Ataxia 12 25%
 Total 46 95.8%
Other cranial nerve manifestations
 Trigeminal neuralgia 3 6.25%
 Isolated facial upper motor 2 4.16%
 Pseudoulbar palsy 1 2.1%
 Total 6 12.5%
Sensory manifestations
 Superficial sensory impairment 21 43.8%
 Deep sensory impairment 22 45.8%
 Total 43 89.6%
Neurogenic bladder manifestations
 Precipitancy, urgency 19 39.6%
 Incontinence 4 8.3%
 Total 23 47.9%
Fatigue 38 79.2%
Spasticity 8 16.7%
Tonic spasms 22 45.8%
Ambulation
 Ambulant 32 66.7%
 Assisted walk 10 20.8%
 Wheelchair bound 6 12.5%